BioPorto A/S (THOXF)
OTCMKTS · Delayed Price · Currency is USD
0.2880
+0.0580 (25.22%)
At close: Jun 26, 2024
BioPorto Market Cap
BioPorto has a market cap or net worth of $90.92 million as of October 24, 2025. Its market cap has decreased by -20.47% in one year.
Market Cap
90.92M
Enterprise Value
84.91M
Revenue
5.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.29
Market Cap Chart
Since March 1, 2005, BioPorto's market cap has increased from 13.34M to 90.92M, an increase of 581.57%. That is a compound annual growth rate of 9.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 90.92M | -1.90% |
| Dec 30, 2024 | 92.68M | -21.24% |
| Dec 29, 2023 | 117.67M | 5.71% |
| Dec 30, 2022 | 111.32M | 10.53% |
| Dec 30, 2021 | 100.71M | -43.36% |
| Dec 30, 2020 | 177.83M | 131.04% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 806.69M |
| Elite Pharmaceuticals | 649.45M |
| Glass House Brands | 618.32M |
| Silence Therapeutics | 342.45M |
| Nika Pharmaceuticals | 335.28M |
| CytoDyn | 319.35M |
| Northwest Biotherapeutics | 305.00M |
| American Oncology Network | 297.14M |